Partner News
Partner News
10/05/2024
“Under the radar” prostate cancer targeted by new research to stop disease returning
Dr Jane Shortall is pioneering a brand-new way to plan, deliver, and follow up on radiotherapy treatments.
Partner News
17/04/2024
Paterson named Building of the Year 2023 by Greater Manchester Chamber of Commerce
The Paterson has been named Building of the Year 2023 by Greater Manchester Chamber of Commerce. Read more about this award and what it means for our partnership.
Partner News
10/04/2024
MCRC Springboard Awards
Read about the MCRC Springboard Awards which support early-stage innovations showing the greatest potential to deliver patient impact with a pump prime funding programme.
Partner News
05/04/2024
Cancer Research UK Manchester Centre to receive £8.5m boost for clinician scientist training
Partner News
25/03/2024
Team Womb to be presented with prestigious AACR award for Team Science
Team Womb, led by Prof. Emma Crosbie, have been given the prestigious AACR Team Science Award for their pioneering work on Lynch-syndrome associated endometrial cancer.
Partner News
21/03/2024
iMATCH to benefit from £17.9m additional funding for Advanced Therapy Treatment Centre network
Partner News
15/11/2023
Dr Kelechi Njoku awarded the first Eve Appeal Fellowship
The Eve Appeal and North West Cancer Research have announced that they are funding Dr Kelechi Njoku, a senior clinical oncology specialty registrar and academic clinical lecturer from The University of Manchester, to develop a new, kinder, test to diagnose womb cancer.
Partner News
19/09/2023
Swinton cancer patient joins a clinical trial at The Christie at Oldham
Partner News
18/09/2023
Research to find new treatment for oesophageal cancer receives £500,000 funding from MRC
The funding will support work to investigate an ‘RNA therapeutic’ to activate the body's immune system.
Partner News
31/08/2023
15 outstanding NHS clinicians and researchers named MAHSC Honorary Clinical Chairs 2023
Partner News
23/08/2023
Trial drug helps rectal cancer patients avoid surgery
Paul Cusick is part of the PRIME RT trial, investigating the combination of immunotherapy, chemotherapy and radiotherapy
Partner News
02/08/2023